# LLM Judge Evaluation: tier1_006

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 2/6

### Reasoning:
Completion:
- The trace shows the agent looked up the SMILES for ketamine and submitted a solubility workflow for ethanol at 298.15 K, but never checked status or retrieved a numerical result. Therefore the workflow started but did not complete, and no result or interpretation was presented.

Correctness:
- No computed value was returned, so accuracy cannot be assessed against literature. I nonetheless located literature values for ketamine (free base) solubility in ethanol at ambient conditions to contextualize the expected magnitude.

Tool Use:
- Positives: correct SMILES for ketamine free base; appropriate solvent (ethanol, CCO) and temperature (298.15 K) for the task; sensible sequence to begin (lookup → submit).
- Negatives: the sequence was incomplete (no poll/retrieval of results); thus no numerical output. This is a process gap rather than parameter misuse.

### Feedback:
- You set up the job correctly but stopped before the critical “check → retrieve → report” steps. Poll the job status and extract the numerical solubility (e.g., mg/mL at 298 K), then briefly interpret it for pharmaceutical relevance.
- Clarify base vs. salt at the outset. For pharmaceutical formulation, ketamine HCl is typically used; its ethanol solubility is orders of magnitude higher than the free base. Include the exact form you’re reporting to avoid ambiguity and to match the user’s intended use case.
- When no computed result is available, report that immediately and provide a literature benchmark so the user isn’t left waiting without a number.
- Literature validation: 1) Agent's computed value
- Not available (workflow not completed; no numerical solubility returned).

2) Literature value with source
- Ketamine free base (R-enantiomer) solubility in ethanol at ambient conditions: approximately 62–83 mg/mL, determined experimentally (approximate method) in a 2024 patent application. ([patents.justia.com](https://patents.justia.com/patent/20240336556?utm_source=openai))
- For context (salt used in pharma): Ketamine hydrochloride is reported by WHO International Pharmacopoeia as “soluble in ethanol (~750 g/L),” i.e., ~750 mg/mL, though vendor datasheets vary. ([drugs-dev.ncats.io](https://drugs-dev.ncats.io/substance/O18YUO0I83?utm_source=openai))

3) Absolute error
- N/A (no agent result to compare).

4) Percent error
- N/A (no agent result to compare).

5) Score justification
- Correctness scored 0/2 because the agent did not provide any numerical result to validate; literature values are provided solely for reference and are not a comparison point.

### Web Search Citations:
1. [U.S. Patent Application for R-KETAMINE SALTS AND METHODS OF USE THEREOF Patent Application (Application #20240336556 issued October 10, 2024) - Justia Patents Search](https://patents.justia.com/patent/20240336556?utm_source=openai)
2. [KETAMINE HYDROCHLORIDE](https://drugs-dev.ncats.io/substance/O18YUO0I83?utm_source=openai)

### Execution:
- **Tools**: submit_solubility_workflow, molecule_lookup
- **Time**: 0.3 min

---
*Evaluated with openai/gpt-5*
